NBIX - Neurocrine Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$204.18
DETAILS
HIGH:
$230.00
LOW:
$165.00
MEDIAN:
$210.00
CONSENSUS:
$204.18
UPSIDE:
50.45%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 371,568 | $62.6M | 0.1% | +11,432 | INCREASED |
| Dalio | 205,677 | $34.7M | 0.1% | +57,536 | INCREASED |
| Cooperman | 5,599 | $943,627 | 0.0% | -83,585 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 42,408 | $117.18 | $5.0M |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 17,147 | $102.90 | $1.8M |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 965 | $103.52 | $100K |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 747 | $133.84 | $100K |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 853 | $117.18 | $100K |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 48,199 | $117.63 | $5.7M |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 27,770 | $136.69 | $3.8M |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | -- | -- | -- |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 51,567 | $103.52 | $5.3M |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 10,087 | $124.12 | $1.3M |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 2,949 | -- | -- |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 60,005 | $79.02 | $4.7M |
| 2026-09-28 | ROBERTS EIRY | officer: Chief Medical Officer | ? | 21,782 | $133.84 | $2.9M |
| 2026-09-11 | Lippoldt Darin | officer: Chief Legal Officer | F-InKind | 2,419 | $156.22 | $378K |
| 2026-09-11 | Gano Kyle | director, officer: Chief Executive Officer | A-Award | 6,275 | -- | -- |
| 2026-09-11 | Delaet Ingrid | officer: Chief Regulatory Officer | A-Award | 4,483 | -- | -- |
| 2026-09-11 | Cooke Julie | officer: Chief Human Resources Officer | A-Award | 3,587 | -- | -- |
| 2026-09-11 | BENEVICH ERIC | officer: Chief Commercial Officer | F-InKind | 3,386 | $156.22 | $529K |
| 2026-09-14 | ABERNETHY MATT | officer: Chief Financial Officer | SELL | 2,311 | $157.20 | $363K |
| 2026-09-11 | ABERNETHY MATT | officer: Chief Financial Officer | A-Award | 5,020 | -- | -- |
| 2026-09-11 | GORMAN KEVIN CHARLES | director | A-Award | 14,343 | -- | -- |
| 2026-09-11 | Gano Kyle | director, officer: Chief Executive Officer | F-InKind | 3,386 | $156.22 | $529K |
| 2026-09-11 | Onyia Jude | officer: Chief Scientific Officer | F-InKind | 1,936 | $156.22 | $302K |
| 2026-09-11 | Gano Kyle | director, officer: Chief Executive Officer | A-Award | 1,842 | -- | -- |
| 2026-09-14 | Boyer David W. | officer: Chief Corp. Affairs Officer | SELL | 826 | $157.45 | $130K |